Secondly, a higher level of circulating insulin-like growth factor I (IGF-I) has been associated with increased risk of prostate cancer both in prospective (Chan et al, 1998a; Stattin et al, 2000) and in case–control studies (Wolk et al, 1998). Here, IGF1 is linked to prostate carcinoma.